These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Reducing recurrent stroke: methodology of the motivational interviewing in stroke (MIST) randomized clinical trial.
    Author: Krishnamurthi R, Witt E, Barker-Collo S, McPherson K, Davis-Martin K, Bennett D, Rush E, Suh F, Starkey N, Parag V, Rathnasabapathy Y, Jones A, Brown P, Te Ao B, Feigin VL, ARCOS IV Programme Group.
    Journal: Int J Stroke; 2014 Jan; 9(1):133-9. PubMed ID: 24165269.
    Abstract:
    RATIONALE: Recurrent stroke is prevalent in both developed and developing countries, contributing significantly to disability and death. Recurrent stroke rates can be reduced by adequate risk factor management. However, adherence to prescribed medications and lifestyle changes recommended by physicians at discharge after stroke is poor, leading to a large number of preventable recurrent strokes. Using behavior change methods such as Motivational Interviewing early after stroke occurrence has the potential to prevent recurrent stroke. AIMS AND/OR HYPOTHESIS: The overall aim of the study is to determine the effectiveness of motivational interviewing in improving adherence to medication and lifestyle changes recommended by treating physicians at and after hospital discharge in stroke patients 12 months poststroke to reduce risk factors for recurrent stroke. DESIGN: Recruitment of 430 first-ever stroke participants will occur in the Auckland and Waikato regions. Randomization will be to intervention or usual care groups. Participants randomized to intervention will receive four motivational interviews and five follow-up assessments over 12 months. Nonintervention participants will be assessed at the same time points. STUDY OUTCOMES: Primary outcome measures are changes in systolic blood pressure and low-density lipoprotein levels 12 months poststroke. Secondary outcomes include self-reported adherence and barriers to prescribed medications, new cardiovascular events (including stroke), changes in quality of life, and mood. DISCUSSION: The results of the motivational interviewing in stroke trial will add to our understanding of whether motivational interviewing may be potentially beneficial in the management of stroke and other diseases where similar lifestyle factors or medication adherence are relevant.
    [Abstract] [Full Text] [Related] [New Search]